Dose Titration Algorithm Tuning (DTAT) should supersede ‘the’ Maximum Tolerated Dose (MTD) in oncology dose-finding trials
From MaRDI portal
Publication:60287
DOI10.12688/F1000RESEARCH.10624.3MaRDI QIDQ60287
Publication date: 17 July 2017
Published in: F1000Research (Search for Journal in Brave)
Related Items (1)
This page was built for publication: Dose Titration Algorithm Tuning (DTAT) should supersede ‘the’ Maximum Tolerated Dose (MTD) in oncology dose-finding trials